Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03182634
Title The UK Plasma Based Molecular Profiling of Advanced Breast Cancer to Inform Therapeutic CHoices (plasmaMATCH) Trial (plasmaMATCH)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Institute of Cancer Research, United Kingdom
Indications

breast carcinoma

Therapies

Fulvestrant

Ceralasertib + Olaparib

Capivasertib

Fulvestrant + Neratinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.